Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Clyyf crawled time : 07:00 save search
Celyad Oncology appoints Georges Rawadi as its new CEO
Published: 2023-03-24 (Crawled : 07:00) - globenewswire.com
CLYYF | $0.4138 -2.36% -1.88% 0
|
n/a
| Email alert
Add to watchlist
CYAD | $0.47 -12.49% 49K
|
Health Technology
| Email alert
Add to watchlist
ceo
Celyad Oncology provides an update on its strategic business model, continuing to focus on opportunities to fully harness the true potential of its proprietary technology platforms and intellectual property
Published: 2022-12-21 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -26.47%
H: 1.33%
C: -3.69%
technology potential update
Celyad Oncology Announces Third Quarter 2022 Financial Results and Recent Business Highlights
Published: 2022-11-10 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 0.48%
H: 3.59%
C: 2.22%
financial results
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2022-05-31 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 2.82%
H: 1.83%
C: 0.46%
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2022-05-31 (Crawled : 07:00) - biospace.com/
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 2.82%
H: 1.83%
C: 0.46%
Celyad Oncology to Announce Full Year 2021 Financial Results and Host Conference Call
Published: 2022-03-17 (Crawled : 07:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 4.76%
H: 0.41%
C: 0.41%
financial results conference cel results
Celyad Oncology Provides Outlook for 2022
Published: 2022-01-10 (Crawled : 07:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 2.39%
H: 2.47%
C: 0.78%
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
Published: 2021-12-31 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -3.21%
H: 5.8%
C: 1.1%
Celyad Oncology Announces January 2022 Conference Schedule
Published: 2021-12-22 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -2.48%
H: 2.28%
C: -1.52%
conference cel
Celyad Oncology Announces First Patient Dosed in KEYNOTE-B79 Phase 1b Trial
Published: 2021-12-16 (Crawled : 07:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 2.91%
H: 0.0%
C: -1.88%
phase 1b trial cel phase 1 phase 2b
Transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
Published: 2021-12-15 (Crawled : 07:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -2.36%
H: 0.0%
C: 0.0%
group
Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition
Published: 2021-12-13 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 1.97%
H: 2.15%
C: -4.52%
Celyad Oncology Announces $32.5 Million Private Placement with Fortress Investment Group
Published: 2021-12-03 (Crawled : 07:00) - globenewswire.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 37.64%
H: 8.57%
C: -4.08%
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CSSE 4 | $0.3499 129.74% 150M
|
Consumer Services
CZOO | $11.04 121.24% 9.6M
|
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.